Humoral Immunity to AAV-6, 8, and 9 in Normal and Dystrophic Dogs
Open accessThe DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
Adeno-associated virus (AAV)-6, 8, and 9 are promising gene-delivery vectors for testing novel Duchenne muscular dystrophy gene therapy in the canine model. Humoral immunity greatly influences in vivo AAV transduction. However, neutralizing antibodies to AAV-6, 8, and 9 have not been systemically examined in normal and dystrophic dogs. To gain information on the seroprevalence of antibodies to AAV-6, 8, and 9, we measured neutralizing antibody titers using an in vitro transduction inhibition assay. We examined 72 naive serum samples and 26 serum samples obtained from dogs that had received AAV gene transfer. Our data demonstrated that AAV-6 neutralizing antibody was the most prevalent antibody in dogs irrespective of age, gender, disease status (dystrophic or not), and prior parvovirus vaccination history. Surprisingly, high-level anti-AAV-6 antibody was detected at birth in newborn puppies. Further, a robust antibody response was induced in affected, but not normal newborn dogs following systemic AAV gene transfer. Taken together, our data have provided an important baseline on the seroprevalence of AAV-6, 8, and 9 neutralizing antibodies in normal and Duchenne muscular dystrophy dogs. These results will help guide translational AAV gene-therapy studies in dog models of muscular dystrophy. Shin and colleagues have conducted a large-scale survey on seroprevalence of AAV-6, -8, and -9 neutralizing antibodies in normal, carrier, and dystrophin-deficient dogs. Their data demonstrate that AAV-6 neutralizing antibody is the most prevalent antibody in dogs irrespective of age, sex, disease status (dystrophic or not), and prior parvovirus vaccination history. High-level anti-AAV-6 antibody is detected as early as birth in newborn puppies. The authors also show that a robust antibody response is induced in affected, but not normal, newborn dogs after systemic AAV gene transfer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Zhong, L., Li, B., Mah, C. S., Govindasamy, L., Agbandje-McKenna, M., Cooper, M., Herzog, R. W., Zolotukhin, I., Warrington, K. H., Weigel-Van Aken, K. A., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0802866105 · Cited by 558 · cited 1×
“These were Y445F AAV-6 tyrosine mutant, AAV-9, and Y731F AAV-9 tyrosine mutant (Zhong et al., 2008; Qiao et al., 2010).”
MethodGene therapy vectors based on adeno-associated virus type 1
Xiao, W., Chirmule, N., Berta, S. C., McCullough, B., Gao, G., & Wilson, J. M. (1999) · Journal of Virology · doi:10.1128/jvi.73.5.3994-4003.1999 · Cited by 541 · cited 4×
“Previous studies suggest that *20–30% of the human population is seropositive to AAV-1 or AAV-6 (Halbert et al., 2006; Calcedo et al., 2009).”
BackgroundInfluentialNew recombinant serotypes of AAV vectors
Gao, G., Vandenberghe, L., & Wilson, J. (2005) · Current Gene Therapy · doi:10.2174/1566523054065057 · Cited by 487
The homologue of the Duchenne locus is defective in X-linked muscular dystrophy of dogs
Cooper, B. J., Winand, N. J., Stedman, H., Valentine, B. A., Hoffman, E. P., Kunkel, L. M., Scott, M.-O., Fischbeck, K. H., Kornegay, J. N., Avery, R. J., et al. (1988) · Nature · doi:10.1038/334154a0 · Cited by 428 · cited 2×
“In several cases, colonies have been established (Cooper et al., 1988; Kornegay et al., 1988; Fine et al., 2011; Smith et al., 2011).”
BackgroundImmune System Development in the Dog and Cat
Day, M. J. (2007) · Journal of Comparative Pathology · doi:10.1016/j.jcpa.2007.04.005 · Cited by 176 · cited 4×
“The newborn puppy thymus contains much fewer T cells (absolute number) (for reviews, see Felsburg, 1998, 2002; Day, 2007).”
BackgroundInfluentialNeutralizing antibodies against AAV serotypes 1, 2, 6, and 9 in sera of commonly used animal models
Rapti, K., Louis-Jeune, V., Kohlbrenner, E., Ishikawa, K., Ladage, D., Zolotukhin, S., Hajjar, R. J., & Weber, T. (2012) · Molecular Therapy · doi:10.1038/mt.2011.177 · Cited by 170 · cited 3×
“Although we cannot completely exclude nonimmunoglobulin inhibitory factors, a recent study by Rapti and co-workers revealed a trend similar to what we have observed here (Rapti et al., 2011).”
BackgroundResultInfluentialThe Pleiotropic Effects of Natural AAV Infections on Liver-directed Gene Transfer in Macaques
Wang, L., Calcedo, R., Wang, H., Bell, P., Grant, R., Vandenberghe, L. H., Sanmiguel, J., Morizono, H., Batshaw, M. L., & Wilson, J. M. (2010) · Molecular Therapy · doi:10.1038/mt.2009.245 · Cited by 130
Gregorevic, P., Schultz, B. R., Allen, J. M., Halldorson, J. B., Blankinship, M. J., Meznarich, N. A., Kuhr, C. S., Doremus, C., Finn, E., Liggitt, D., et al. (2009) · Molecular Therapy · doi:10.1038/mt.2009.116 · Cited by 40 · cited 2×
“AAV-6, 8, and 9 are currently the most promising AAV serotypes in canine DMD gene-therapy studies (Wang et al., 2007; Yue et al., 2008; Gregorevic et al., 2009; Ohshima et al., 2009).”
Background
Cited by
Emerging issues in AAV-mediated in vivo gene therapy
Colella, P., Ronzitti, G., & Mingozzi, F. (2018) · Molecular Therapy - Methods & Clinical Development · doi:10.1016/j.omtm.2017.11.007 · Cited by 881
Animal models of Duchenne muscular dystrophy: from basic mechanisms to gene therapy
McGreevy, J. W., Hakim, C. H., McIntosh, M. A., & Duan, D. (2015) · Disease Models & Mechanisms · doi:10.1242/dmm.018424 · Cited by 512
Self-citationHumoral immune response to AAV
Calcedo, R., & Wilson, J. M. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00341 · Cited by 243
“Interestingly, high levels of AAV6 NAbs are found in newborn puppies suggesting passive immunization from colostrum and breast milk (45).”
BackgroundRescuing AAV gene transfer from neutralizing antibodies with an IgG-degrading enzyme
Elmore, Z. C., Oh, D. K., Simon, K. E., Fanous, M. M., & Asokan, A. (2020) · JCI Insight · doi:10.1172/jci.insight.139881 · Cited by 137
Calcedo, R., & Wilson, J. M. (2016) · Human Gene Therapy Clinical Development · doi:10.1089/humc.2016.048 · Cited by 77
Metadata
- Authors
- Shin, J.-H., Yue, Y., Smith, B., & Duan, D.
- Venue
- Human Gene Therapy
- Publisher
- SAGE Publications
- Published
- 2012-03
- Volume
- 23
- Issue
- 3
- Pages
- 287-294
- ISSN
- 1043-0342 (ISSN-L)
- 1557-7422
- OpenAlex
- W1964628542
- Cited by
- 33
- References
- 8
- FWCI
- 1.10
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Humoral Immunity to AAV-6, 8, and 9 in Normal and Dystrophic Dogs. https://app.cochat.ai/papers/10.1089/hum.2011.125
- The paper
- Shin, J.-H., Yue, Y., Smith, B., & Duan, D. (2012). Humoral Immunity to AAV-6, 8, and 9 in Normal and Dystrophic Dogs. Human Gene Therapy. https://doi.org/10.1089/hum.2011.125
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.